StoneX Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $444K | Buy |
+5,709
| New | +$461K | 0.02% | 621 |
|
|
2026
Q1 | – | Sell |
-5,880
| Closed | -$569K | – | 1115 |
|
|
2025
Q4 | $569K | Buy |
5,880
+86
| +1% | +$8.35K | 0.02% | 492 |
|
|
2025
Q3 | $556K | Sell |
5,794
-22
| -0.4% | -$2.02K | 0.02% | 503 |
|
|
2025
Q2 | $511K | Sell |
5,816
-2,750
| -32% | -$233K | 0.02% | 497 |
|
|
2025
Q1 | $773K | Buy |
8,566
+53
| +0.6% | +$4.74K | 0.04% | 354 |
|
|
2024
Q4 | $683K | Buy |
8,513
+1,858
| +28% | +$161K | 0.04% | 385 |
|
|
2024
Q3 | $603K | Buy |
6,655
+1,706
| +34% | +$144K | 0.04% | 309 |
|
|
2024
Q2 | $393K | Sell |
4,949
-418
| -8% | -$34.3K | 0.03% | 393 |
|
|
2024
Q1 | $471K | Sell |
5,367
-61
| -1% | -$5.21K | 0.04% | 325 |
|
|
2023
Q4 | $451K | Sell |
5,428
-388
| -7% | -$29.6K | 0.04% | 320 |
|
|
2023
Q3 | $460K | Buy |
5,816
+252
| +5% | +$21.1K | 0.05% | 306 |
|
|
2023
Q2 | $493K | Sell |
5,564
-923
| -14% | -$79.5K | 0.05% | 294 |
|
|
2023
Q1 | $527K | Buy |
6,487
+1,381
| +27% | +$113K | 0.06% | 289 |
|
|
2022
Q4 | $399K | Sell |
5,106
-36
| -0.7% | -$2.92K | 0.05% | 336 |
|
|
2022
Q3 | $418K | Buy |
5,142
+1,116
| +28% | +$100K | 0.06% | 304 |
|
|
2022
Q2 | $364K | Buy |
4,026
+328
| +9% | +$33.2K | 0.04% | 362 |
|
|
2022
Q1 | $413K | Sell |
3,698
-212
| -5% | -$22.4K | 0.03% | 399 |
|
|
2021
Q4 | $407K | Buy |
3,910
+397
| +11% | +$46K | 0.05% | 336 |
|
|
2021
Q3 | $443K | Buy |
3,513
+340
| +11% | +$44K | 0.06% | 280 |
|
|
2021
Q2 | $396K | Buy |
3,173
+734
| +30% | +$92.2K | 0.06% | 292 |
|
|
2021
Q1 | $289K | Sell |
2,439
-204
| -8% | -$23.9K | 0.05% | 309 |
|
|
2020
Q4 | $311K | Buy |
2,643
+230
| +10% | +$25.3K | 0.07% | 261 |
|
|
2020
Q3 | $252K | Buy |
2,413
+7
| +0.3% | +$703 | 0.08% | 256 |
|
|
2020
Q2 | $222K | Buy |
+2,406
| New | +$231K | 0.08% | 252 |
|
|
2020
Q1 | – | Sell |
-2,082
| Closed | -$237K | – | 293 |
|
|
2019
Q4 | $237K | Buy |
2,082
+171
| +9% | +$18.8K | 0.1% | 252 |
|
|
2019
Q3 | $209K | Buy |
+1,911
| New | +$199K | 0.13% | 238 |
|
|
2017
Q3 | – | Sell |
-10,532
| Closed | -$935K | – | 280 |
|
|
2017
Q2 | $935K | Buy |
+10,532
| New | +$888K | 0.29% | 124 |
|
Other funds holding MDT
StoneX Group's MDT Position: Q2 2026 in Review
StoneX Group opened a new position in Medtronic (MDT) in Q2 2026: 5,709 shares worth $444K. The stake represents 0.02% of the portfolio and ranks #621 among its holdings. This is a return to the name: StoneX Group previously reported a position in MDT as recently as Q4 2025.
StoneX Group first reported a position in MDT in Q2 2017 and has held it in 27 quarters since. The position peaked at $935K in Q2 2017. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- StoneX Group held 5,709 shares of Medtronic worth $444K as of Q2 2026.
- Medtronic was a new StoneX Group position in Q2 2026.
- Medtronic made up 0.02% of StoneX Group's portfolio in Q2 2026, its #621 holding.
- StoneX Group first reported a position in Medtronic in Q2 2017 and has held it in 27 quarters since.
- StoneX Group's Medtronic position peaked at $935K in Q2 2017.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.